SEC Form 4 · accession 0001179110-15-004187
INVIVO THERAPEUTICS HOLDINGS CORP. · NVIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Masuoka K. Lorianne
Officer — Chief Medical Officer
Period of report
Mar 2, 2015
Accepted (ET)
Mar 4, 2015 · 4:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001292519
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.02 | Mar 2, 2015 | A | 500,000 | A | — | Mar 2, 2025 | Common Stock | 500,000 | 500,000 | D |
Explanation of responses
- F1The option is exercisable as to 25% of the shares on the first anniversary of the date of grant, and the remaining shares vest thereafter on a monthly basis in 36 equal monthly installments.